Monday, November 23, 2026

Tata Elxsi sets up offshore tech centre in Pune for AI-driven healthcare solutions

Date:

Tata Elxsi announced on Thursday, March 19, the launch of a global offshore development centre (ODC) for Tokyo-based Terumo Corporation, aimed at strengthening the development of advanced cardiac and vascular solutions.

The newly inaugurated ‘Terumo–Tata Elxsi Offshore Development Center’ will support engineering, innovation and end-to-end lifecycle management of Terumo’s medical technologies across global markets. The collaboration is expected to enhance product development speed while ensuring compliance with international regulatory standards, stated the exchange filing.

The ODC will bring together multidisciplinary teams, leveraging Tata Elxsi’s capabilities in design, engineering, verification, regulatory compliance and localisation. It will also integrate AI and GenAI-led digital technologies into software engineering processes to enable faster innovation, improved cost efficiency and greater product differentiation, according to an exchange filing.

The partnership is focused on advancing the performance and reliability of cardiac and vascular devices, while addressing the growing demand for patient-centric medical solutions worldwide.

Also Read: NBCC bags housing, infra orders worth ₹320 crore

Fumihisa Hirose, Company President, Cardiac & Vascular Company at Terumo Corporation, said the ODC will help the company innovate faster and deliver high-quality medical technologies across markets. He added that Tata Elxsi’s integrated expertise will support the acceleration of its global product roadmap while maintaining high standards of safety and compliance.

Sreevatsa Sahasranaman, Senior Vice President and Head of Healthcare & Life Sciences at Tata Elxsi, said the centre represents a long-term strategic partnership aimed at driving innovation and cost efficiencies across Terumo’s cardiovascular portfolio. He noted that the collaboration will combine design, engineering and regulatory strengths, enhanced by AI and GenAI technologies, to enable the rollout of next-generation medical devices in both global and emerging markets.

Shares of Tata Elxsi ended lower on Thursday, March 19, by 4% at ₹4,039.30 on the NSE.

Also Read: Tata Elxsi launches DevStudio.ai to speed up automotive software engineering

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

CLSA sees better US-India trade outlook; expects Fed and RBI to raise rates in December

The US is likely to push ahead with trade...

‘Trump has cost us’: After midterm losses, MAGA asks if it’s over

As Republicans faced a nationwide drubbing in Tuesday’s midterm...

Prashant Jain sees 12-15% annual returns from Indian equities over 3-5 years

Question We've had a very painful period for the equity...

Raamdeo Agrawal sees FIIs return as earnings improve and valuations turn attractive

Question Looking at the valuation compression across the market, are...